Access to Medicine Foundation 347d ago

In this episode of The Health Equity podcast, Jayasree K. Iyer, CEO of the Access to Medicine Foundation, speaks with Dr Joseph Saba, CEO of Axios International, about how pharmaceutical companies are addressing access challenges and the role of measurement in driving progress. Drawing on insights from the 2024 Access to Medicine Index, they discuss what it takes to translate commitments into action in low- and middle-income countries. Dr Saba shares insights from decades of experience, from the early days of the HIV/AIDS response to today’s evolving landscape of global health. The conversation highlights key access strategies, the importance of collaboration and what more needs to be done to ensure that life-saving medicines reach the people who need them most. With global health funding under increasing pressure, they also discuss what this means for pharmaceutical companies working to expand access. As the funding landscape shifts, companies and other stakeholders must find new ways to adapt and sustain progress. 🔔 Subscribe for more insightful conversations on access to medicine and global health. Visit our website 👉 https://accesstomedicinefoundation.org/ Follow us on social media: LinkedIn 👉 https://www.linkedin.com/company/access-to-medicine-foundation/ BlueSky 👉 https://bsky.app/profile/accesstomedicinefoundation.org X 👉 https://twitter.com/atmindex #podcast #AccesstoMedicine #AccesstoHealthcare #EquitableAccess #GlobalHealth #pharma